Teleflex to Showcase Advanced Interventional Below-the-Knee (BTK) Products at LINC 2016
22 January 2016 - 10:45PM
Business Wire
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical devices for critical care, urology and surgery, will
showcase its Arrow® GPSCath® Interventional Product Platform at the
Leipzig Interventional Course (LINC) to be held in Leipzig, Germany
on January 26 - 29, 2016.
During the event, Teleflex will highlight the Arrow® GPSCath®
Balloon Dilatation Catheter, which features VisioValve™ Technology.
The GPSCath® Catheter is a specialty two-in-one device that is
indicated for percutaneous transluminal angioplasty (PTA) in the
peripheral vasculature, including the iliac, femoral, popliteal,
infrapopliteal and renal arteries.
Teleflex is pleased to present its Arrow® GPSCath® Catheter at
three Satellite Symposiums during the event. The first presentation
will be given by Dr. Marco Manzi from Policlinico Abano Terme,
Italy and is entitled “Use of the Arrow® GPSCath® Catheter in a
diabetic patient population with impaired renal function.” This
presentation will be held at the Global Expert Exchange, Room 5, on
Tuesday, January 26 at 15:24h.
The second presentation will be given by Prof. Marc Sapoval from
Hôpital Européen Georges Pompidou, Paris, France and is entitled
“Strategies in challenging BTK procedures: Arrow® GPSCath®
Catheters with VisioValve™ Technology to protect wire placement,
reduce fluoroscopy-time and minimize contrast media.” This
presentation will be held on Thursday, January 28, at 11:00h, at
Technical Forum, Room 3.
The third presentation is entitled “Contrast saving strategies
for BTK recanalization with the Arrow® GPSCath® Catheter,” and will
be given by Dr. Costantino Del Giudice from Hôpital Européen
Georges Pompidou, Paris, France on Thursday, January 28, at 16:23h,
at Main Arena 1, Room 1.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose driven innovation – a relentless pursuit of identifying
unmet clinical needs – to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular and interventional access, surgical, anesthesia,
cardiac care, urology, emergency medicine and respiratory care.
Teleflex employees worldwide are united in the understanding that
what we do every day makes a difference. For more information,
please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rüsch® and Weck® – trusted brands united by a common
sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, GPSCath, Hudson
RCI, LMA, Pilling, Rusch, VisioValve and Weck are trademarks or
registered trademarks of Teleflex Incorporated or its affiliates,
in the U.S. and/or other countries. © 2016 Teleflex Incorporated.
All rights reserved.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160122005060/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836orMartina Teichmann-ZindlerDirector
Marketing Communications International+49
(0)7151-406-538martina.teichmann@teleflex.com
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2024 to May 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From May 2023 to May 2024